|Full name ||European Clinical Research Infrastructure Network|
|Operational status||fully operational|
|Director General||Jacques Demotes|
|RI member countries||DE, ES, FR, HU, IT, NO, PT|
christine.kubiak [at] ecrin.org
This sections provides an overview on the national subsidiaries of the RI.
|F-CRIN – French Clinical Research |
Contact: Amélie Michon
|KKSN – Netzwerk der Koordinierungs-|
zentren für Klinische Studien
Contact: Anke Strenge-Hesse
|HECRIN – Hungarian Clinical Research |
Contact: Zita Tarjányi
|Istituto Superiore di Sanità (ISS)|
Contact: Arianna Valerio
|Norwegian Clinical Research Infra-|
Contact: Valentina Cabral Iversen
|PtCRIN – Portuguese Clinical Research |
Contact: Catarina Madeira
|SCReN – Spanish Clinical Research |
Contact: Joaquín Sáez Peñataro, Eva Lopez Guerrero
|CZECRIN - Czech Clinical Research |
Contact: Lenka Souckova
|Swiss Clinical Trial Organisation|
Contact: Caecilia Schmid
Description of the organisation
Since its creation in 2004, ECRIN has been striving to overcome the challenges to multinational trials in Europe.
ECRIN focuses on multinational academic research as well as trials initiated by biotech and medical device small and medium enterprises (SMEs). It provides support to sponsors in investigator-initiated trials and helps them navigate Europe’s fragmented health and legal systems. Multi-country trials means greater access to patients, resources, and expertise, and, in turn, faster and potentially more robust results.
ECRIN’s organisational model is based on country membership. Each country has a European Correspondent, who manages the trial portfolio and coordinates with the national scientific hub (i.e. network of clinical trial units, CTUs) with support from the Paris-based Core Team.
ECRIN provides support for the preparation of multinational clinical trials (e.g. trial logistics, funding applications), the validation of study protocols (scientific and logistical review), and trial management (coordination, submissions to competent authorities and ethics committees; monitoring; adverse event reporting; data management). In support of these activities, it develops and maintains freely accessible tools such as databases on regulatory and ethical requirements, outcome measures, and risk-based monitoring.
ECRIN currently provides consultancy and management services to more than 40 trials, with an average of seven countries per trial.
In addition, ECRIN contributes to capacity building projects aiming to establish shared services in biomedical areas and to foster international cooperation in non-commercial trials.
A list of services offered by ECRIN can be downloaded here.